Ambuja Cements (AMBUJACEM) — deviation variation

Ambuja Cements reported no deviations or variations in fund utilization for Q3 FY2025-26. The company raised ₹15,000.046 crores through preferential issue of equity shares (warrant conversions) across two tranches in March-April 2024. As of December 31, 2025, ₹14,895.1 crores had been utilized against the original allocation for capital expenditures, de-bottlenecking, logistics infrastructure, acquisitions, and general corporate purposes. The Audit Committee reviewed and confirmed zero deviation.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this deviation variation affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 30 January 2026?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 30 January 2026

TATASTEEL Tata Steel Limited Announcement RECLTD REC Limited Financial Results ULTRACEMCO UltraTech Cement Limited Financial Results VEDL Vedanta Limited Financial Results VEDL Vedanta Limited Annual Report WIPRO Wipro Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.